NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
NanoVibronix, Inc. (NAOV)
NASDAQ:AMEX Investor Relations:
otcmarkets.com/stock/naov/profile
Company Research
Source: Business Wire
Research expected to advance to ‘Full Study’ phase in 2025 ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the successful completion of the first phase of a Randomized Control Trial study of UroShield® by researchers at the University of Michigan (“UM”).This first phase of the trial is a precursor to the full study by researchers at UM. It was conducted primarily with nursing home residents and was aimed at studying the impact of UroShield® on improving patient’s quality of life by its potential to reduce urinary tract infections, catheter blockages and pain caused by the long-term use of urinary catheters.Brian Murphy, Chief Executive Officer of the Company, commented, “The first phase of the study served as a validation pilot in advance of a full study. With this phase now compl
Show less
Read more
Impact Snapshot
Event Time:
NAOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAOV alerts
High impacting NanoVibronix, Inc. news events
Weekly update
A roundup of the hottest topics
NAOV
News
- NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes [Yahoo! Finance]Yahoo! Finance
- NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen PrototypesBusiness Wire
- NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan [Yahoo! Finance]Yahoo! Finance
- NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement [Yahoo! Finance]Yahoo! Finance
- NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution AgreementBusiness Wire
NAOV
Sec Filings
- 1/7/25 - Form 8-K
- 1/6/25 - Form 8-K
- 1/3/25 - Form 4
- NAOV's page on the SEC website